skip to main content

S. 2004 (115th): Combating the Opioid Epidemic Act


The text of the bill below is as of Oct 25, 2017 (Introduced). The bill was not enacted into law.


II

115th CONGRESS

1st Session

S. 2004

IN THE SENATE OF THE UNITED STATES

October 25, 2017

(for himself, Mr. Markey, Ms. Hassan, Mr. Heinrich, Mrs. Shaheen, Mr. Kaine, Mrs. Feinstein, Ms. Klobuchar, Mr. Franken, Mr. King, Ms. Baldwin, Ms. Warren, Mr. Brown, Mr. Menendez, Ms. Harris, Mr. Udall, and Mr. Nelson) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

A BILL

To increase funding for the State response to the opioid misuse crisis and to provide funding for research on addiction and pain related to the substance misuse crisis.

1.

Short title

This Act may be cited as the Combating the Opioid Epidemic Act.

2.

Additional funding for the State response

(a)

Funding

Section 1003 of the 21st Century Cures Act (42 U.S.C. 290ee–3 note) is amended—

(1)

in subsection (a), by striking under subsection (b) and inserting under subsection (b)(3) and the appropriations under subsection (b)(4);

(2)

in subsection (b), by adding at the end the following:

(4)

Additional appropriations

In addition to the amounts transferred to the Account under paragraph (2)(A), there are authorized to be appropriated, and there are appropriated, to the Secretary, out of monies in the Treasury not otherwise obligated, $4,474,800,000 for each of fiscal years 2018 through 2027, to carry out the grant program described in subsection (c). Such funds shall remain available until expended.

; and

(3)

by striking subsection (f).

(b)

Activities

Section 1003(c)(1) of the 21st Century Cures Act (42 U.S.C. 290ee–3 note) is amended—

(1)

by redesignating subparagraph (E) as subparagraph (G); and

(2)

by inserting after subparagraph (D) the following:

(E)

Detection, surveillance, and treatment of co-occurring infections associated with the opioid epidemic, including hepatitis C and HIV.

(F)

Surveillance, data collection, and timely and consistent reporting on the number of opioid overdose deaths, including the incidence and prevalence of co-occurring infections and toxicology reporting on the number of deaths where fentanyl or other illicit opioid analogs were detected.

.

3.

Grants for research on addiction and pain

(a)

In general

The Secretary of Health and Human Services (referred to in this section as the Secretary) shall use any funds appropriated under subsection (b) to award grants for the purpose of conducting research on addiction and pain related to substance misuse. The Secretary, acting through the Director of the National Institutes of Health, shall determine the amount of each grant awarded under this section.

(b)

Appropriations

There are authorized to be appropriated, and there are appropriated, to the Secretary, out of monies in the Treasury not otherwise obligated, $50,400,000 for each of fiscal years 2018 through 2022, to carry out the grant program described in subsection (a). Such funds shall remain available until expended.